Diseases of the Conjunctiva Practice Questions

Q: Cicatrising trachoma is seen in which stage?

Stage 3. **Explanation:** Trachoma, caused by *Chlamydia trachomatis* (serotypes A, B, Ba, and C), is traditionally classified using the **McCallan Classification**, which divides the clinical course into four stages based on conjunctival changes. * **Stage 3 (Stage of Cicatrization):** This is the correct answer. This stage is characterized by the presence of **scarring (cicatrization)** of the palpebral conjunctiva. A hallmark finding here is **Arlt’s line**, a horizontal band of scarring located at the junction of the anterior one-third and posterior two-thirds of the tarsal conjunctiva. This scarring eventually leads to complications like trichiasis and entropion. **Analysis of Incorrect Options:** * **Stage 1 (Incipient Trachoma):** Characterized by immature follicles on the upper tarsal conjunctiva and early corneal changes (superficial keratitis). No scarring is present. * **Stage 2 (Established Trachoma):** Defined by mature follicles and papillary hypertrophy. It is the stage of active inflammation. * **Stage 4 (Stage of Sequelae):** This is the stage of "healed trachoma." The disease is inactive, and the patient presents with the late-stage consequences of scarring, such as corneal opacity and xerosis. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Classification (FISTO):** Remember the mnemonic for active/chronic stages: **F**ollicular, **I**ntense inflammation, **S**carring, **T**richiasis, **O**pacity. * **Herbert’s Pits:** These are pathognomonic clinical signs of trachoma, representing scarred-down limbal follicles. * **Treatment:** The drug of choice is a single dose of **Azithromycin** (20 mg/kg). * **SAFE Strategy:** WHO-recommended strategy for control: **S**urgery, **A**ntibiotics, **F**acial cleanliness, **E**nvironmental improvement.

Q: Which of the following is NOT true regarding epidemic keratoconjunctivitis?

Enterovirus. **Explanation:** Epidemic Keratoconjunctivitis (EKC) is a highly contagious, severe form of viral conjunctivitis. **1. Why Enterovirus is the correct answer (The "NOT" true statement):** EKC is caused by **Adenovirus**, specifically serotypes **8, 19, and 37**. Enteroviruses (such as Enterovirus 70 and Coxsackievirus A24) are the causative agents of **Acute Hemorrhagic Conjunctivitis (AHC)**, which is characterized by rapid onset and prominent subconjunctival hemorrhages, rather than the chronic corneal involvement seen in EKC. **2. Analysis of other options:** * **Superficial Punctate Keratitis (SPK):** This is the initial corneal manifestation of EKC, occurring within the first week of infection due to active viral replication in the epithelium. * **Pseudomembrane formation:** Severe inflammation in EKC often leads to the formation of pseudomembranes (fibrinous exudate on the palpebral conjunctiva). If left untreated, these can lead to conjunctival scarring. * **Subepithelial Infiltrates (SEIs):** These are a hallmark of EKC, appearing around day 11–15. They represent an immune response to viral antigens and can persist for months, causing blurred vision and glare. **Clinical Pearls for NEET-PG:** * **Rule of 8:** EKC is often associated with Adenovirus type 8; symptoms typically appear 8 days after exposure; and the first 8 days are the most infectious. * **Preauricular Lymphadenopathy:** A classic clinical sign of viral conjunctivitis (including EKC). * **Treatment:** Primarily supportive. Topical steroids are reserved for vision-threatening SEIs or dense pseudomembranes but should be used cautiously as they may prolong viral shedding.

Q: Arlt's line is seen in which condition?

Trachoma. **Explanation:** **Arlt’s line** is a classic clinical sign of **Trachoma**, a chronic keratoconjunctivitis caused by *Chlamydia trachomatis* (serotypes A, B, Ba, and C). It represents a horizontal band of scar tissue (cicatrization) located in the upper tarsal conjunctiva, specifically at the junction of the anterior one-third and posterior two-thirds. It occurs due to the healing of lymphoid follicles and chronic inflammation, leading to the contraction of the conjunctiva. **Analysis of Options:** * **Trachoma (Correct):** Characterized by the "SAFE" strategy. Arlt’s line is a hallmark of the cicatricial stage (WHO Stage: Trachomatous scarring - TS). * **Vernal Keratoconjunctivitis (VKC):** Associated with "cobblestone" papillae on the superior tarsal conjunctiva and Horner-Tranta’s dots at the limbus, but not linear scarring like Arlt’s line. * **Pterygium:** A degenerative condition involving a fibrovascular proliferation of the subconjunctival tissue onto the cornea (Stocker’s line may be seen here). * **Ocular Pemphigoid:** A chronic cicatrizing conjunctivitis that leads to symblepharon and ankyloblepharon, but the scarring is diffuse and involves the fornices rather than forming a specific horizontal line on the tarsus. **High-Yield Clinical Pearls for Trachoma:** 1. **Herbert’s Pits:** Small circular depressions on the limbus (pathognomonic) representing healed follicles. 2. **Sago-grain follicles:** Typical appearance of follicles in the upper tarsal conjunctiva. 3. **Pannus:** Vascularization of the upper part of the cornea. 4. **Entropion and Trichiasis:** Common late complications due to conjunctival scarring. 5. **Treatment:** Single dose of Oral Azithromycin (20 mg/kg) is the drug of choice.

Q: What is the drug of choice for Spring Catarrh?

Olopatadine. **Explanation:** **Spring Catarrh**, also known as **Vernal Keratoconjunctivitis (VKC)**, is a bilateral, recurrent, external ocular inflammation primarily affecting young males in hot, dry climates. It is a Type I (IgE-mediated) and Type IV hypersensitivity reaction. **Why Olopatadine is the Correct Answer:** Modern management of VKC prioritizes drugs with **dual action**. Olopatadine acts as both a **potent H1-receptor antagonist** and a **mast cell stabilizer**. This dual mechanism provides rapid symptomatic relief from itching while preventing further degranulation of mast cells. It is currently considered the first-line maintenance therapy (Drug of Choice) due to its superior efficacy and better dosing profile (twice daily) compared to older agents. **Analysis of Incorrect Options:** * **Topical Steroids (Option A):** While steroids are the most effective for controlling acute "exacerbations" or "pulses," they are **not** the drug of choice for long-term management due to the high risk of sight-threatening side effects like steroid-induced glaucoma and cataracts. * **Palivizumab (Option B):** This is a monoclonal antibody used for the prevention of Respiratory Syncytial Virus (RSV) in infants; it has no role in ophthalmology. * **Sodium Chromoglycate (Option C):** This is a pure mast cell stabilizer. It has a slow onset of action (takes 5–10 days to work) and requires frequent dosing (4 times daily), making it less effective than dual-action agents like Olopatadine. **High-Yield Clinical Pearls for NEET-PG:** * **Hallmark signs:** Cobblestone papillae (Palpebral form) and Horner-Trantas dots (Limbal form). * **Shield Ulcer:** A sterile, indolent oval ulcer seen in the upper cornea in severe VKC. * **Refractory cases:** If dual-action drugs fail, topical **Cyclosporine** or **Tacrolimus** are used as steroid-sparing agents.

Q: Diagnosis of the given condition is:

Pterygium. ***Pterygium*** - A **triangular fibrovascular growth** that extends from the **conjunctiva onto the cornea**, crossing the **limbus** (junction between cornea and conjunctiva). - Typically grows from the **nasal side** and can cause **astigmatism** or **visual impairment** if it reaches the visual axis. *Episcleritis* - Presents as **localized redness** and **mild discomfort** without any growth or tissue proliferation. - It's a **vascular inflammation** of the episclera, not a fibrous growth extending onto the cornea. *Bitot spots* - Appear as **foamy, triangular patches** on the **bulbar conjunctiva** due to **vitamin A deficiency**. - They are **whitish-gray plaques** associated with **conjunctival xerosis**, not fibrovascular growths. *Pinguecula* - A **yellowish, elevated lesion** on the **bulbar conjunctiva** that does **not cross the limbus**. - It remains **confined to the conjunctiva** and does not extend onto the corneal surface like pterygium.

Q: A 7-year-old patient presents with a conjunctival nodule, with a history of previous TB treatment. The nodule has now encroached onto the limbus. What is the most likely diagnosis?

Phlyctenular keratoconjunctivitis. **Explanation:** **Phlyctenular Keratoconjunctivitis (PKC)** is the most likely diagnosis. It is a **Type IV delayed hypersensitivity reaction** of the conjunctiva and cornea to endogenous microbial proteins. In developing countries like India, the most common allergen is **Tuberculoprotein** (from *Mycobacterium tuberculosis*), while in developed nations, it is often *Staphylococcus aureus*. * **Why it is correct:** The patient’s age (common in children), history of TB, and the clinical presentation of a nodule at the limbus are classic for PKC. The "phlycten" typically starts as a small, pinkish-white nodule surrounded by a zone of hyperemia, often located at or near the limbus. **Analysis of Incorrect Options:** * **Trachoma:** Caused by *Chlamydia trachomatis* (Serotypes A-C). It presents with follicles and papillae on the upper tarsal conjunctiva, not a solitary limbal nodule. * **Vernal Keratoconjunctivitis (VKC):** A Type I IgE-mediated hypersensitivity. While it can present with limbal nodules (Horner-Trantas dots), these are usually multiple, transient, and associated with intense itching and "cobblestone" papillae. * **Limbal Stem Cell Deficiency:** Presents with conjunctivalization of the cornea and loss of limbal palisades, usually following chemical burns or chronic inflammation, not as an acute nodule. **High-Yield Clinical Pearls for NEET-PG:** * **Triad of PKC:** Photophobia, lacrimation, and blepharospasm (more severe when the cornea is involved). * **Fascicular Ulcer:** A characteristic wandering ulcer formed when a limbal phlycten moves towards the center of the cornea, carrying a leash of blood vessels behind it. * **Management:** Topical steroids for the nodule; however, always rule out or treat the underlying systemic cause (e.g., Chest X-ray/Mantoux test for TB).

Q: Ophthalmia nodosa is seen with which of the following conditions?

Caterpillar hair in conjunctiva. **Explanation:** **Ophthalmia nodosa** is a granulomatous inflammatory reaction of the eye caused by the penetration of **caterpillar hairs** (setae) or certain plant hairs into the ocular tissues. 1. **Why the correct answer is right:** Caterpillar hairs possess tiny barbs that allow them to migrate deeper into the eye (conjunctiva, cornea, or even the iris and vitreous). The body reacts to these foreign bodies by forming **yellowish-grey nodules** (granulomas) in the conjunctiva, hence the name "nodosa." This is a classic example of a foreign body granulomatous reaction. 2. **Analysis of incorrect options:** * **Onchocerciasis (River Blindness):** Caused by the nematode *Onchocerca volvulus*. While it causes ocular inflammation (keratitis, uveitis), it does not present as Ophthalmia nodosa. * **Pseudoexfoliation syndrome:** A systemic condition characterized by the deposition of white, flaky amyloid-like material on the anterior segment (lens capsule, pupillary margin). It is associated with glaucoma, not granulomatous nodules. * **Pinguecula:** A common degenerative condition of the conjunctiva caused by UV exposure, appearing as a yellowish-white deposit near the limbus. It is not an inflammatory reaction to foreign hairs. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** The hairs migrate due to their barbed structure and the mechanical action of blinking. * **Pathology:** Histology shows a **Type IV hypersensitivity** (granulomatous) reaction with giant cells surrounding the hair. * **Management:** Immediate removal of visible hairs. If hairs migrate intraocularly, they can cause severe endophthalmitis-like reactions requiring surgical intervention. * **Differential Diagnosis:** Often confused with Parinaud’s Oculoglandular Syndrome, but the history of contact with insects/caterpillars is key.

Q: Conjunctiva in vitamin A deficiency shows which of the following changes?

Hyperplasia of squamous epithelium. **Explanation:** Vitamin A (Retinol) is essential for maintaining the integrity of epithelial surfaces. In the eye, it acts as a differentiating agent for the conjunctival and corneal epithelium. **Why Option A is Correct:** Vitamin A deficiency leads to a process called **Squamous Metaplasia**. Under normal conditions, the conjunctiva is composed of non-keratinized stratified columnar epithelium. When Vitamin A is deficient, there is a loss of mucus-secreting goblet cells and a transformation of the epithelium into a **keratinized stratified squamous** type. This involves **hyperplasia of the squamous epithelium**, leading to the characteristic dryness (Xerosis) and the formation of Bitot’s spots (keratin debris). **Why Other Options are Incorrect:** * **B. Actinic degeneration:** This refers to damage caused by UV radiation, typically seen in conditions like Pinguecula or Pterygium, not nutritional deficiencies. * **C. Macrophage infiltration:** While chronic inflammation may involve macrophages, the hallmark histological change in Xerophthalmia is epithelial transformation (metaplasia), not primary histiocytic infiltration. * **D. Hyperplasia of goblet cells:** This is the opposite of what occurs. Vitamin A deficiency causes a **marked decrease or total loss** of goblet cells, which is the primary reason for the loss of the tear film’s mucin layer. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Classification (Xerophthalmia):** X1A (Conjunctival xerosis), X1B (Bitot’s spots), X2 (Corneal xerosis), X3A/B (Keratomalacia). * **Bitot’s Spots:** Triangular, foamy, silvery-white patches usually located on the **temporal** bulbar conjunctiva. * **Earliest Symptom:** Night blindness (Nyctalopia). * **Earliest Sign:** Conjunctival xerosis (loss of luster). * **Treatment:** WHO schedule (200,000 IU orally on days 0, 1, and 14 for children >1 year).

Q: Follicle formation may be seen in all of the following except?

Vernal keratoconjunctivitis. **Explanation:** The core concept tested here is the differentiation between **Follicular** and **Papillary** conjunctival responses. **Why Vernal Keratoconjunctivitis (VKC) is the correct answer:** VKC is a Type I hypersensitivity reaction (allergic). The hallmark clinical finding in VKC is **Papillae** formation (specifically "cobblestone" papillae on the superior tarsal conjunctiva). Papillae are vascular structures with a central fibrovascular core, whereas follicles are lymphoid aggregates. Therefore, VKC does not typically present with follicles. **Analysis of Incorrect Options:** * **Trachoma (Option A):** Caused by *Chlamydia trachomatis* (Serotypes A, B, Ba, C). It is a classic cause of follicular conjunctivitis, particularly involving the upper tarsal conjunctiva. * **Inclusion Conjunctivitis (Option C):** Caused by *Chlamydia trachomatis* (Serotypes D-K). It presents as an acute follicular conjunctivitis, typically involving the inferior fornix. * **Epidemic Keratoconjunctivitis (Option D):** Caused by Adenovirus (Types 8, 19, 37). Viral infections are the most common cause of acute follicular conjunctivitis. **High-Yield Clinical Pearls for NEET-PG:** * **Follicles:** Look like "grains of rice." They are subepithelial lymphoid follicles (B-cells/T-cells) and **lack** a central vessel (vessels run over the surface). * **Causes of Follicles:** Remember the mnemonic **"CHAV"**: **C**hlamydia, **H**erpes simplex, **A**denovirus, and **V**ariations (Toxic/Molluscum). * **Papillae:** Have a "red dot" in the center (central vessel). Seen in **Allergic** conditions (VKC, GPC) and **Bacterial** conjunctivitis. * **Herbert’s Pits:** These are scarred follicles at the limbus, pathognomonic for Trachoma.

Q: What is the most common malignant cancer of the conjunctiva?

Squamous cell carcinoma. **Explanation:** **Squamous Cell Carcinoma (SCC)** is the most common primary malignant tumor of the conjunctiva. It typically arises from **Conjunctival Intraepithelial Neoplasia (CIN)**, often at the limbus within the interpalpebral fissure. The primary risk factors include chronic exposure to ultraviolet (UV-B) radiation, Human Papillomavirus (HPV) types 16 and 18, and immunosuppression (e.g., HIV/AIDS). Clinically, it presents as a pearly-white, fleshy mass with "feeder vessels" and can be plaque-like, nodular, or fungating. **Analysis of Incorrect Options:** * **Basal Cell Carcinoma (BCC):** While BCC is the most common malignancy of the **eyelids**, it does not arise from the conjunctiva because the conjunctiva lacks the hair follicles and sebaceous structures from which BCC originates. * **Dermoid:** A limbal dermoid is a common **benign** congenital choristoma (normal tissue in an abnormal location), not a malignancy. It is often associated with Goldenhar syndrome. * **Papilloma:** This is a **benign** epithelial tumor. While it can be associated with HPV, it is not a cancerous lesion. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Incisional or excisional biopsy. * **Treatment:** Wide local excision using the "No-touch technique" combined with cryotherapy to the margins. * **Adjuvant Therapy:** Topical Mitomycin-C (MMC), 5-Fluorouracil (5-FU), or Interferon alpha-2b are used to prevent recurrence. * **Precursor Lesion:** CIN is also known as "Bowen’s disease of the conjunctiva" when it involves the full thickness of the epithelium.

Question 1

Cicatrising trachoma is seen in which stage?

Accepted Answer

Stage 3

Answer

Stage 1

Answer

Stage 2

Answer

Stage 4

Question 2

Which of the following is NOT true regarding epidemic keratoconjunctivitis?

Accepted Answer

Enterovirus

Answer

Superficial punctate keratitis

Answer

Pseudomembrane formation

Answer

Subepithelial infiltrates

Question 3

Arlt's line is seen in which condition?

Accepted Answer

Trachoma

Answer

Vernal keratoconjunctivitis

Answer

Pterygium

Answer

Ocular pemphigoid

Question 4

What is the drug of choice for Spring Catarrh?

Accepted Answer

Olopatadine

Answer

Topical Steroids

Answer

Palivizumab

Answer

Sodium chromoglycate

Question 5

Diagnosis of the given condition is:

Accepted Answer

Pterygium

Answer

Episcleritis

Answer

Bitot spots

Answer

Pinguecula

Question 6

A 7-year-old patient presents with a conjunctival nodule, with a history of previous TB treatment. The nodule has now encroached onto the limbus. What is the most likely diagnosis?

Accepted Answer

Phlyctenular keratoconjunctivitis

Answer

Trachoma

Answer

Vernal keratoconjunctivitis

Answer

Limbus stem cell deficiency

Question 7

Ophthalmia nodosa is seen with which of the following conditions?

Accepted Answer

Caterpillar hair in conjunctiva

Answer

Onchocerciasis

Answer

Pseudoexfoliation syndrome

Answer

Pinguecula

Question 8

Conjunctiva in vitamin A deficiency shows which of the following changes?

Accepted Answer

Hyperplasia of squamous epithelium

Answer

Actinic degeneration

Answer

Macrophage infiltration

Answer

Hyperplasia of goblet cells

Question 9

Follicle formation may be seen in all of the following except?

Accepted Answer

Vernal keratoconjunctivitis

Answer

Trachoma

Answer

Inclusion conjunctivitis

Answer

Epidemic keratoconjunctivitis

Question 10

What is the most common malignant cancer of the conjunctiva?

Accepted Answer

Squamous cell carcinoma

Answer

Basal cell carcinoma

Answer

Dermoid

Answer

Papilloma

Diseases of the Conjunctiva — MCQs

Diseases of the Conjunctiva — MCQs

On this page

Practice by Chapter

Want unlimited practice?